Upregulation of miR-31* Is Negatively Associated with Recurrent/Newly Formed Oral Leukoplakia

Abstract

BackgroundOral leukoplakia (OLK) is a potentially malignant disorder of the oral cavity. However, the underlying mechanism of OLK is still unclear. In this study, we explore possible miRNAs involved in OLK.Methodology/Principal FindingsUsing miRNA microarrays, we profiled miRNA expression in OLK and malignantly transformed OLK (mtOLK) tissue samples. The upregulation of miR-31*, miR-142-5p, miR-33a, miR-1259, miR-146b-5p, miR-886-3p, miR-886-5p, miR-519d, and miR-301a along with the downregulation of miR-572, miR-611, miR-602, miR-675, miR-585, miR-623, miR-637, and miR-1184 in mtOLK were new observations. Fluorescence in situ hybridization (FISH) analyses confirmed that miR-31* is highly expressed in mtOLK. There was a significant difference between the FISH score (p<0.05) in patients with or without recurrent/newly formed OLK. Functional analyses demonstrated that a miR-31* inhibitor decreased apoptosis in the Leuk-1, which is an immortalized oral epithelial cell line spontaneously derived from an oral leukoplakia lesion. miR-31* regulated apoptosis, cell proliferation, migration, and invasion in the HOIEC, which is a HPV E6/E7-immortalized oral epithelial cell line. Furthermore, miR-31* modulated the biological functions of apoptosis, cell proliferation, cell cycle, migration, and invasion in the oral squamous cell carcinoma cell line, Cal-27. Using bioinformatic analyses and dual luciferase reporter assays, we determined that the 3′ untranslated region of fibroblast growth factor 3 (FGF3) is the target of miR-31*. Expression of FGF3 was downregulated or upregulated in the presence of a miR-31* mimic or inhibitor, respectively.Conclusions/SignificanceUpregulation of miR-31* is negatively associated with recurrent/newly formed OLK. MiR-31* may exert similar but distinguishable effects on biological function in oral cells with different malignant potential. FGF3 is the target of miR-31*. miR-31* may play an important role during OLK progression through regulating FGF3. MiRNA* strands may also have prominent roles in oral carcinogenesis.

Role of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samples

“…The downregulation of miR-623 expression levels in malignantly transformed oral leukoplakia has previously been observed (41). However, in the present study, miR-623 was significantly upregulated in tumor tissues compared with adjacent normal tissue (P<0.01; Fig.…”

Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer

“…1, b). A decrease of miR-1184 expression is detected in malignant transformation of leukoplakia of the oral cavity [15]. No more data on the relationship between malignant tumors and hsamiR-1184 seems to be available.…”

MicroRNAs and head and neck cancer: Reviewing the first decade of research

“…This was again a limited study of 12 patients but suggests that miRNAs could be used as a signature to stratify leucoplakia at risk of malignant transformation. Xiao et al found a panel of 72 upregulated and 50 downregulated miRNAs when comparing oral leucoplakia (ranging from non-dysplastic to severely dysplastic) to OSCC [149]. Though these were all significantly differentially expressed, the level of fold-change (e.g.…”